-
SK Biopharmaceuticals’ ';Cenobamate' Surpasses $100 Mil. in Quarterly Sales in U.S.
06 Aug 2025 09:41 GMT
… .
On Aug. 5, SK Biopharmaceuticals announced through its second quarter … operating leverage effect.”
SK Biopharmaceuticals is seeking market expansion through … for accounting purposes.
Meanwhile, SK Biopharmaceuticals is pursuing the external introduction …
-
SK biopharmaceuticals hits record Q2 earnings on Xcopri US sales surge
06 Aug 2025 05:09 GMT
SK biopharmaceuticals hit an all-time high … improvement in cost efficiency,” SK biopharmaceuticals said in its earnings release … AI-powered epilepsy care.
SK biopharmaceuticals is also preparing for a …
-
Metis Technologies Closes RMB 400 Million Series D Financing To Power Beijing's Biopharmaceutical Innovation Engine
05 Aug 2025 01:05 GMT
(MENAFN- PR Newswire)
The Series D round was co-led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund. The new capital will be used to accelerate METiS' core strategic initiatives, including automation …
-
Bio Usawa and Sartorius Stedim Biotech forge partnership to pioneer biopharmaceutical manufacturing in Africa
02 Aug 2025 04:09 GMT
… France), a global partner of biopharmaceutical manufacturing, have announced a partnership … to accelerate Africa’s biopharmaceutical industry and address the … scientists, and produce innovative biopharmaceuticals that are accessible and affordable …
-
Pasadena-Based Biopharmaceutical Firm Xencor Names Veteran Scientist to Board
01 Aug 2025 18:35 GMT
… .]Xencor Inc., a clinical-stage biopharmaceutical company headquartered in Pasadena, has …
-
Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032
06 Aug 2025 14:57 GMT
… Inc. (Innovent), a world-class biopharmaceutical company, announced that the US … 2025.
Innovent is a leading biopharmaceutical company founded in 2011 with … worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, …
-
US FDA clears CASI Pharma’s IND application for CID-103 in renal allograft antibody-mediated rejection
06 Aug 2025 14:56 GMT
… Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing innovative … .
CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and …
-
Immix Biopharma Announces Other Serious Diseases Strategy
06 Aug 2025 16:30 GMT
… ” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for … : IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for …
-
BioHub Maryland in Rockville holds biopharma training for Bowie State students
06 Aug 2025 17:34 GMT
… for hands-on training in biopharmaceutical manufacturing.
“To have a school … , students have been learning about biopharmaceutical manufacturing skills such as upstream …
-
Cingulate Submits New Drug Application To FDA For Lead ADHD Asset Ctx-1301
06 Aug 2025 14:04 GMT
… Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision … Inc. (NASDAQ: CING), is a biopharmaceutical company utilizing its proprietary PTR …
About
© 1995-2025